Menu
BACK TO START PAGE

Veterinary

Introduction to Equashield

VETERINARY

USAGE

Read more

Close

Compounding chemotherapy without proper PPE/Engineering Controls has been linked to both acute and long-term health risks, including cancer.

Short bursts of exposure to hazardous drugs over a long period of time may pose a long term health risk. EQUASHIELD’s easy to use CSTD protects you and your staff from hazardous drug leaks, sprays or aerosols that can be created during drug preparation, administration and disposal.

EQUASHIELD’s easy to use vial adaptors make accessing the vial a breeze, without a need of any assembly fixture.

EQUASHIELD’s Syringe Unit with prefilled sterile air prevents environmental contamination from entering the drug vial, protecting our companion animals. Intuitively designed connectors, make the system extremely simple to use under any conditions.

If you are already using a Closed System today or are thinking about incorporating a Closed System in your Veterinary practice, consider EQUASHIELD CSTD as it is Safe, Simple and Closed.

EQUASHIELD IN ACTION

Somethings,

You have to see it to Believe it.

No Mirrors

Just Smoke

Clinical Evidence

CLINICALLY PROVEN, ELIMINATES SURFACE CONTAMINATION

“Use of Equashield CSTD eliminates surface contamination with antineoplastic agents” Cleveland Clinic Cancer Center, OH Bernadette A Clark and Paul JM Sessink

“CONTAINMENT TESTING TO ASSESS THE EFFICACY OF CLOSED SYSTEM TRANSFER”
Ifosfamide, Methotrexate & Etoposide Wipe Tested on CSTD Connectors
Joseph Arminger, Alyson Leonard, Adam Peele, Crystal Peyton; Cone Health Cancer Center

CONNECTORS DRUG LEAKAGE STUDY

DRY MEMBRANES, EVEN WITH 5FU

Download PDF

CLEAN OR CONTAMINATED?

CHOICE IS YOURS!

“Syringe plunger contamination by hazardous drugs: A comparative study” Barbara Ann Karmanos Cancer Center, Detroit, MI, Stephen T Smith and Mark C Szlaczky

DRY CONNECTOR SEEN BEST IN THE DARK

“Fluorescent Evaluation of Dry Connections in the EQUASHIELD, Phaseal and Tevadaptor/Onguard Closed System Drug Transfer Devices” Migal Analytical Chemistry Laboratory, K.SHMONA, ISRAEL DR. IGAL BAR-ILAN

IN VETERINARY PRACTICE

PRACTICALLY PERFECT

“Treatment time, ease of use and cost associated with use of Equashield, PhaSeal, or no CSTD for administration of cancer chemotherapy to a dog model” Multisite study: College of Veterinary Medicine University of Georgia and 11 Clinics and Hospitals. K. Kicenuik, N. Northrup et al.

5FU LEAKAGE STUDY

“Connector integrity testing to assess the efficacy of multiple closed system transfer devices” Eshelman School of Pharmacy, University of North Carolina
Shawn O. Streeter, Charlotte M. Forshay, Stephanie A. Salch, Stephen F. Eckel

MITIGATE RISK!

“Evaluation of syringes used for compounding hazardous drugs and the contamination risks to healthcare personnel”
Study Presented at the ASHP Midyear 2014 Residents Poster Session

OFTEN, SEEING IS BELIEVING

“Comparative Study of Vapor Containment EFFI­ciency of Hazardous Drug Transfer Devices” Migal Analytical Chemistry Laboratory, K.SHMONA, ISRAEL DR. IGAL BAR-ILAN

CUT THE TIME TO COMPOUND IN HALF, TIME SAVED IS MONEY EARNED

“Assessing the efficiency of CSTDs for compounding”

Fouzia Berdi, Pharm.D., Michael F Powell, MS. FASHP et al.

THE ULTRA VIOLET COMPARISON

“CLOSED-SYSTEM DRUG TRANSFER DEVICES: COMPARATIVE STUDY OF DIFFERENT MODELS” MASSON F., HENRY C., LANHER P., NOIREZ V., RONDELOT G.; SERVICE DE PHARMACIE – CENTRE HOSPITALIER RÉGIONAL METZ-THIONVILLE – HÔPITAL DE MERCY – ARS-LAQUENEXY

MORE ROUTES OF EXPOSURE

“Comparative Study of Syringe Contamination by Hazardous Drugs” Institute of Energy and Environmental Technology, Duisburg, Germany DR. THEKLA KIFFMEYER, DR. BerTRAND Favier

PREVENTS MICROBIAL INGRESS UP TO 7 DAYS*

“A 7 Days Microbial Ingress Test of Single Use Vials Utilizing the EQUASHIELD CSTD” Study by Nelson Laboratories, Salt Lake City, UT

VAPOR CONTAINMENT STUDY

“Application of vapor containment protocol for CSTD to assess efficacy
during pharmacy compounding and administration of HD” Eshelman School of Pharmacy, University of North Carolina
Charlotte M. Forshay, Shawn O. Streeter, Stephanie A. Salch, Stephen F. Eckel

ALCOHOL BRINGS OUT THE TRUTH

“Evaluation of Equashield CSTD Compatibility in Prevention of Environmental Contamination, Alcohol vapors detection” Milouda & Migal Laboratories, K.SHMONA, ISRAEL

DON’T TOUCH, CONTAMINATED

“Contamination of syringe plungers during the sampling of cyclophosphamide solutions” Le´on Be´rard Cancer Center, Lyon, France Bertrand Favier, Laurence Gilles et al.

RIPE FOR PICKING!

SAVINGS IS A LOW HANGING FRUIT

“Economic impact of extending the beyond-use date of chemotherapy single-dose vials through the use of a cSTD” MOUNT SINAI HOSPITAL, NEW YORK, NY SARAH KATOR, Chung-Shien Lee et al

Regulatory Recommendations

ONB code

“Equashield is cleared by the FDA under the ONB code for Closed Antineoplastic and hazardous reconstitution and transfer systems”

NIOSH VAPOR PROTOCOL

“A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs” THE NIOSH DRAFT PROTOCOL

USP 800

“USP CHAPTER 800 – HAZARDOUS DRUGS -HANDLING IN HEALTHCARE SETTINGS”

PREVENTING EXPOSURES TO HAZARDOUS DRUGS

“Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings” NIOSH

Use Videos

WITHDRAWING

FROM A VIAL

IV push or bolus

administration

Using Equashield

Y-site tubing

Additional Information

HOW IT WORKS

HOW IT WORKS

SYSTEM COMPONENTS

SYSTEM COMPONENTS

HOW TO USE

HOW TO USE

HOW IT WORKS

HOW IT WORKS

CLINICAL EVIDENCE

CLINICAL EVIDENCE

TECHNICAL SPECIFICATION

THE EQUASHIELD SYSTEM 

ORDERING INFORMATION

ORDERING INFORMATION

DRUG COMPATIBIITY

“Treanda Bendamustine, ETOPOSIDE, BUSULFAN and PACLITAXEL Antineoplastic Drugs Compatibility with the EQUASHIELD CSTD” Milouda & Migal Laboratories, K.SHMONA, ISRAEL Dr. Igal Bar-Ilan